Ono Pharmaceutical Co Stock Investor Sentiment

OPHLF Stock  USD 11.03  1.47  11.76%   
Roughly 61% of Ono Pharmaceutical's investor base is looking to short. The analysis of overall sentiment of trading Ono Pharmaceutical Co pink sheet suggests that many investors are alarmed at this time. The current market sentiment, together with Ono Pharmaceutical's historical and current headlines, can help investors time the market. In addition, many technical investors use Ono Pharmaceutical stock news signals to limit their universe of possible portfolio assets.
Ono Pharmaceutical pink sheet news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Ono daily returns and investor perception about the current price of Ono Pharmaceutical Co as well as its diversification or hedging effects on your existing portfolios.
  
over a month ago at news.google.com         
Vanguard Health Care Funds Strategic Moves Spotlight on Ono Ph - GuruFocus.com
Google News at Macroaxis
over a month ago at news.google.com         
Equillium Maintains Rights to Itolizumab Following Ono Partnership - StockTitan
Google News at Macroaxis
over two months ago at news.google.com         
Kinaxis Inc. to Bolster Supply Chain Operations of Ono Pharmaceutical Co., Ltd - Marketscreener.com
Google News at Macroaxis
over two months ago at news.google.com         
Is It Smart To Buy Ono Pharmaceutical Co., Ltd. Before It Goes Ex-Dividend - Simply Wall St
Google News at Macroaxis
over three months ago at news.google.com         
We Think Ono Pharmaceutical Can Stay On Top Of Its Debt - Simply Wall St
Google News at Macroaxis
over three months ago at news.google.com         
Ono Pharmaceutical Co., Ltd. First-Quarter Results Just Came Out Heres What Analysts Are Forecasting...
Google News at Macroaxis
over three months ago at news.google.com         
Ono Pharmaceutical Co., Ltd. Sees Large Decrease in Short Interest - Defense World
Google News at Macroaxis
over three months ago at news.google.com         
Ono Pharmaceutical Advances Governance and Diversity - TipRanks
Google News at Macroaxis
over six months ago at news.google.com         
Ono Acquires Deciphera Pharmaceuticals - Contract Pharma
Google News at Macroaxis
over six months ago at news.google.com         
Ono Pharmaceutical wraps up 2.4 billion Deciphera buyout By Investing.com - Investing.com
Google News at Macroaxis
over six months ago at news.google.com         
Ono Pharmaceutical Sets New 1-Year Low at 14.23 - Defense World
Google News at Macroaxis
over six months ago at news.google.com         
Ono Pharmaceutical Shares Down 1.3 percent - Defense World
Google News at Macroaxis
over six months ago at news.google.com         
Deciphera acquisition by ONO Pharmaceutical at 2.4 billion By Investing.com - Investing.com
Google News at Macroaxis
over six months ago at news.google.com         
ONO to acquire Deciphera Pharmaceuticals in 2.4B deal - Seeking Alpha
Google News at Macroaxis
over six months ago at news.google.com         
Why Is Cancer Focused Deciphera Pharmaceuticals Stock Skyrocketing On Monday - Deciphera Pharmaceuti...
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Ono Pharmaceutical that are available to investors today. That information is available publicly through Ono media outlets and privately through word of mouth or via Ono internal channels. However, regardless of the origin, that massive amount of Ono data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Ono Pharmaceutical news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Ono Pharmaceutical relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Ono Pharmaceutical's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Ono Pharmaceutical alpha.

Ono Pharmaceutical Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Ono Pink Sheet analysis

When running Ono Pharmaceutical's price analysis, check to measure Ono Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ono Pharmaceutical is operating at the current time. Most of Ono Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Ono Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ono Pharmaceutical's price. Additionally, you may evaluate how the addition of Ono Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
CEOs Directory
Screen CEOs from public companies around the world
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets